Development Level

Tbio 12 | 11,445
Tchem 3 | 1,598

IMPC Phenotype

abnormal cecum morphology 1 | 7
abnormal seminal vesicle morph... 1 | 114
abnormal vibrissa morphology 1 | 25
decreased circulating phosphat... 1 | 27
decreased eosinophil cell numb... 1 | 24
decreased heart weight 1 | 27
decreased lymphocyte cell numb... 1 | 83
enlarged cecum 1 | 5
enlarged heart 1 | 210
enlarged uterus 1 | 11
increased eosinophil cell numb... 1 | 11
increased fasted circulating g... 1 | 76
increased mean corpuscular vol... 1 | 92
increased neutrophil cell numb... 1 | 46
small superior vagus ganglion 1 | 74

Disease

ovarian cancer 11 | 8,520
lung carcinoma 10 | 2,843
Carcinoma 9 | 11,493
lung cancer 9 | 4,740
psoriasis 9 | 6,694
tuberculosis 9 | 2,010
Breast cancer 8 | 3,578
glioblastoma 8 | 5,792
medulloblastoma, large-cell 8 | 6,241
Cancer 7 | 2,499
cutaneous lupus erythematosus 7 | 1,057
osteosarcoma 7 | 7,950
diabetes mellitus 6 | 1,728
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
lung adenocarcinoma 6 | 2,716
pancreatic ductal adenocarcinoma liver metastasis 6 | 1,962
Atherosclerosis 5 | 291
Liver Cirrhosis, Experimental 5 | 769
Rheumatoid arthritis 5 | 1,191
Schizophrenia 5 | 1,160
cystic fibrosis 5 | 1,696
dermatomyositis 5 | 966
interstitial cystitis 5 | 2,312
ulcerative colitis 5 | 1,819
Adverse reaction to drug 4 | 61
Astrocytoma, Pilocytic 4 | 3,081
Autosomal recessive predisposition 4 | 1,442
Brain Injuries 4 | 65
Cerebrovascular disease 4 | 238
Coronary artery disease 4 | 268
Drug-Related Side Effects and Adverse Reactions 4 | 62
Gastrointestinal Hemorrhage 4 | 52
Obesity 4 | 678
Peritonitis 4 | 43
Pneumonia 4 | 174
Venous Thrombosis 4 | 47
adult high grade glioma 4 | 3,801
chronic lymphosyte leukemia 4 | 204
gastric carcinoma 4 | 807
group 4 medulloblastoma 4 | 1,855
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
invasive ductal carcinoma 4 | 2,951
juvenile dermatomyositis 4 | 1,187
malignant mesothelioma 4 | 3,232
mucosa-associated lymphoid tissue lymphoma 4 | 484
non-small cell lung cancer 4 | 2,890
Afibrinogenemia 3 | 4
Afibrinogenemia, congenital 3 | 3
Allergic hypersensitivity disease 3 | 126
Arthritis 3 | 290
Asthma 3 | 385
Bleeding tendency 3 | 37
Chemical and Drug Induced Liver Injury 3 | 195
Cholestasis 3 | 155
Colorectal Neoplasms 3 | 243
Congenital afibrinogenemia 3 | 11
Congenital hypofibrinogenemia 3 | 3
Dysfibrinogenemia, Congenital 3 | 3
Epistaxis 3 | 43
Familial dysfibrinogenemia 3 | 3
Familial hypofibrinogenemia 3 | 3
Gastritis 3 | 47
Gingival Hemorrhage 3 | 18
Hypersensitivity reaction type II disease 3 | 253
Hypertensive disease 3 | 292
Hypofibrinogenemia 3 | 4
Inflammation 3 | 120
Intermenstrual heavy bleeding 3 | 4
Joint swelling 3 | 26
Keloid 3 | 37
Liver disease 3 | 237
Malaria 3 | 160
Mastitis 3 | 48
Perinatal necrotizing enterocolitis 3 | 21
Reperfusion Injury 3 | 86
Sepsis 3 | 24
Spontaneous abortion 3 | 113
Thrombophilia 3 | 38
active Crohn's disease 3 | 922
adrenocortical carcinoma 3 | 1,428
aldosterone-producing adenoma 3 | 665
atypical teratoid / rhabdoid tumor 3 | 5,112
breast carcinoma 3 | 1,638
ependymoma 3 | 4,679
esophageal adenocarcinoma 3 | 737
periodontitis 3 | 293
subependymal giant cell astrocytoma 3 | 2,287
Atopic dermatitis 2 | 952
Chronic obstructive pulmonary disease 2 | 184
Contact Dermatitis 2 | 81
Dermatitis, Contact 2 | 71
Myocardial Ischemia 2 | 169
acute quadriplegic myopathy 2 | 1,158
chronic rhinosinusitis 2 | 512
fibroadenoma 2 | 559
hepatocellular carcinoma 2 | 547
nasopharyngeal carcinoma 2 | 1,058
pancreatic carcinoma 2 | 562
pituitary cancer 2 | 1,972

Tissue

Blood and immune system 15 | 16,909
Digestive Tract 15 | 17,369
Endocrine System 15 | 18,159
Female tissues 15 | 17,400
Liver and Pancreas 15 | 16,750
Male tissues 15 | 17,142
Skin and soft tissues 15 | 17,230
Urinary Tract 15 | 16,678
Respiratory system 14 | 16,393
Cardiovascular System 13 | 15,192
Nervous System 13 | 16,725

Target Family

Non-IDG 14 | 12,091
Transcription Factor 1 | 1,400

Reactome Pathway

Regulation of TLR by endogenou... 15 | 15
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Lymphocyte antigen 96 LY96 Tchem Non-IDG -2.77678 541.2 369
Protein S100-A1 S100A1 Tbio Non-IDG -2.47381 296.0 704
Fibrinogen alpha chain FGA Tbio Non-IDG -2.88066 753.1 595
Fibrinogen gamma chain FGG Tbio Non-IDG -2.21041 158.7 384
Lipopolysaccharide-binding protein LBP Tbio Non-IDG -2.61682 357.2 225
Toll-like receptor 6 TLR6 Tbio Non-IDG -2.18033 129.1 692
Platelet glycoprotein 4 CD36 Tbio Non-IDG -2.63884 376.0 1155
Fibrinogen beta chain FGB Tbio Non-IDG -2.09043 116.8 352
Protein S100-A9 S100A9 Tbio Non-IDG -2.67812 470.9 599
High mobility group protein B1 HMGB1 Tbio Transcription Factor -3.05199 2190.4 1145